Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 182

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 182
---
 in any such activity;                                                                                                |

| ● | been found by a court of                                                                                                         
 competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or 
 state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;                              |

| ● | been the subject of, or                                                                                                                 
 a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended   
 or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any        
 federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance      
 companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty 
 or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire    
 fraud or fraud in connection with any business entity; or                                                                               |

| ● | been the subject of, or                                                                                                             
 a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined 
 in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or  
 any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated 
 with a member.                                                                                                                      |

2022 Equity Incentive Plan On November 22, 2022, the Board and majority stockholder adopted the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the “Plan”). The Plan provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) nonstatutory stock options, (iii) stock appreciation rights, (iv) restricted stock awards, (v) restricted stock unit awards and (vi) other stock awards. The Plan is intended to help us secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for our success and any of our affiliates and provide a means by which the eligible recipients may benefit from increases in value of the common stock. As of March 27, 2025, the Board has reserved 215,452 shares of common stock issuable upon the grant of awards under the Plan, of which 57,